Prevalence and Severity of Urogenital Symptoms in Postmenopausal Women Receiving Endocrine Therapy for Breast Cancer
Authors:
- Mateya TrinkausMTMateya Trinkaus
- Christine SimmonsCSChristine Simmons
- Candi FlynnCFCandi Flynn
- George DranitsarisGDGeorge Dranitsaris
- Robyn BolivarRBRobyn Bolivar
- Mark ClemonsMCMark Clemons
- 1 May 2009
- journal article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 9 (2) , 108-117
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast CancerNew England Journal of Medicine, 2005
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Aromatase Inhibitors in Breast CancerNew England Journal of Medicine, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trialThe Lancet, 2002
- Hormone Receptors in Breast Cancer: Racial Differences in Distribution and SurvivalBreast Cancer Research and Treatment, 2002
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJournal of Clinical Oncology, 2001
- Menopause and breast cancer: Symptoms, late effects, and their managementSeminars in Oncology, 2001
- Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer GroupJournal of Clinical Oncology, 2001
- Anastrozole Is Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer in Postmenopausal Women: Results of a North American Multicenter Randomized TrialJournal of Clinical Oncology, 2000